Cancer treatment adherence among low-income women with breast or gynecologic cancer: A randomized controlled trial of patient navigation

Cancer

Volumn 115, Issue 19, 2009, Pages 4606-4615

  Ell, Kathleen ^a   Vourlekis, Betsy ^b   Xie, Bin ^a   Nedjat Haiem, Frances R ^a   Lee, Pey Jiuan ^a   Muderspach, Laila ^c   Russell, Christy ^c   Palinkas, Lawrence A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adherence; Adjuvant cancer treatment; Hispanics; Low income; Patient navigation

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HISPANIC; HORMONAL THERAPY; HUMAN; LOWEST INCOME GROUP; MEDICAL INFORMATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELEPHONE; THERAPY DELAY; TREATMENT REFUSAL; UTERINE CERVIX CANCER; BREAST TUMOR; FEMALE GENITAL TRACT TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATIENT EDUCATION; POVERTY; QUALITY OF LIFE; SURVIVAL;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GENITAL NEOPLASMS, FEMALE; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; POVERTY; QUALITY OF LIFE; SURVIVAL ANALYSIS;

EID: 70349288309     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24500     Document Type: Article

References (59)

1. Lenzer J. US cancer mortality falls for the first time [serial online]. BMJ. 2006;332:444.
2. Blackman DJ, Masi CM. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol. 2006;24:2170-2178.
3. Irby K, Anderson WF, Henson DE, Devesa SS. Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev. 2006;15:792-797.
4. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006;24:2179-2187.
5. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168-183. (Pubitemid 43847927)
6. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer. 2003;97:2853-2860.
7. Bigby J, Holmes MD. Disparities across the breast cancer continuum. Cancer Causes Control. 2005;16:35-44. (Pubitemid 40568849)
8. Bickell NA, LePar F, Wang JJ, Leventhal H. Lost opportunities: physicians' reasons and disparities in breast cancer treatment. J Clin Oncol. 2007;25:2516-2521. (Pubitemid 47041223)
9. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357-1362. (Pubitemid 46621998)
10. Du Xianglin L, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for earlystage breast cancer in women, 1992 to 2002. Ethn Dis. 2007;17:122-128.
11. Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer. 2002;95:1759-1766.
12. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49-56. (Pubitemid 36091600)
13. Naeim A, Hurria A, Leake B, Maly RC. Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity. Crit Rev Oncol Hematol. 2006;59:234-242.
14. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357. (Pubitemid 34257478)
15. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23:6639-6646. (Pubitemid 46190258)
16. Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opinion Obstet Gynecol. 2007;19:31-36. (Pubitemid 46095870)
17. Byers TE, Wolf HJ, Bauer MS, et al. The impact of socioeconomic status on survival after cancer in the United States. Cancer. 2008;5:241-246.
18. Kim SH, Ferrante J, Won BR, Hammeed M. Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for black women after breast cancer treatment. J Surg Oncol. 2008;6:26-29.
19. Thomas BC, Thomas I, Nandamohan V, Nair MK, Pandey M. Screening for distress can predict loss of follow-up and treatment in cancer patients: results of development and validation of the Distress Inventory for Cancer Version 2 [serial online]. Psychooncology. 2009;18:524-533.
20. Kirk MC, Hudis CA. Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clin Breast Cancer. 2008;8:155-161.
21. Magai C, Consedine N, Neugut AI, Hershman DL. Common psychosocial factors underlying breast cancer screening and breast cancer treatment adherence: a conceptual review and synthesis. J Womens Health (Larchmt). 2007;16:11-23. (Pubitemid 46302740)
22. Vargas RB, Ryan GW, Jackson CA, Rodriquez R, Freeman HP. Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer. 2008;113:426-433.
23. Gabram SG, Lund MJ, Gardner BS, et al. Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African- American population. Cancer. 2008;113:602-607.
24. Ell K, Vourlekis B, Lee P-J, Xie B. Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med. 2007;44:26-33. (Pubitemid 46073077)
25. Meyerowitz BE, Richardson J, Hudson S, Leedham B. Ethnicity and cancer outcomes: behavioral and psychosocial considerations. Psychol Bull. 1998;123:47-70. (Pubitemid 128770175)
26. Bruner DW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol. 2006;24:2209-2215. (Pubitemid 46630694)
27. Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008;112:900-908.
28. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, co-morbidities and demographics? Cancer. 2008;112:171-180.
29. Schleinitz MD, DePalo D, Blume J, Stein M. Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med. 2006;21:1253-1260.
30. Formenti SC, Meyerowitz BE, Ell K, et al. Inadequate adherence to radiotherapy in Latina immigrants with carcinoma of the cervix: potential impact on disease free survival. Cancer. 1995;75:1135-1140.
31. Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987;5:1469-1476. (Pubitemid 18049881)
32. Richardson JL, Marks G, Johnson CA, et al. Path model of multidimensional compliance with cancer therapy. Health Psych. 1987;6:183-207.
33. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990;8:356-364. (Pubitemid 20056570)
34. Li BD, Brown WA, Ampil F, Burton G, Yu H, McDonald JC. Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conversation therapy. Ann Surg. 2000;231:883-889. (Pubitemid 30350247)
35. Srokowski TP, Fang S, Duan Z, et al. Completion of adjuvant radiation therapy among women with breast cancer. Cancer. 2008;113:22-39. (Pubitemid 351976382)
36. Dobie SA, Baldwin LM, Dominitz JA, et al. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst. 2006;98:610-619. (Pubitemid 43904844)
37. Becker M, Drachman R, Kirscht P. A new approach to explaining sick-role behavior in low-income populations. Am J Pub Health. 1974;64:205-216.
38. Bernal G, Bonilla J, Bellido C. Ecological validity and cultural sensitivity for outcome research: issues for the cultural adaptation and development of psychosocial treatments with Hispanics. J Abnormal Psychol. 1995;23:67-82.
39. Ruiz P. The role of culture in psychiatric care. Am J Psychiatry. 1998;155:1763-1765.
40. Cleeland CS. Pain assessment in cancer. In: Osaba D, ed. Effect of Cancer on Quality of Life. Boca Raton, Fla: CRC Press; 1991:293-305.
41. Anderson K, Mendoza T, Valero V, et al. Minority cancer patients and their providers: pain management attitudes and practice. Cancer. 2000;88:1929-1938. (Pubitemid 30213004)
42. Mor V, Laliberte L, Morris JN, Wiermann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. J Clin Oncol. 1984;2:1170-1176. (Pubitemid 14127662)
43. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579. (Pubitemid 23071057)
44. Cella D, Hernandez L, Corona M, et al. Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Med Care. 1998;36:1407-1417. (Pubitemid 128452870)
45. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613. (Pubitemid 32823891)
46. Wittkampf KA, Naeije L, Schene AH, et al. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psych. 2007;29:388-395. (Pubitemid 47410307)
47. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13:595-605.
48. Willms DG, Best JA, Taylor DW, et al. A systematic approach for using qualitative methods in primary prevention research. Med Anthropol Q. 1990;4:391-409.
49. Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago, Ill: Aldine; 1967.
50. Strauss AL, Corbin J. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks, Calif: Sage Publications; 1998.
51. Miles MB, Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook. 2nd ed. Thousand Oaks, Calif: Sage Publications; 1994.
52. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcome. CA Cancer J Clin. 2008;58:9-31.
53. Ell K, Xie B, Wells A, et al. Economic stress among low-income women with cancer: effects on quality of life. Cancer. 2008;112:616-625. (Pubitemid 351186202)
54. Dwight-Johnson M, Ell K, Lee PJ. Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study. Psychosomatics. 2005;46:224-232. (Pubitemid 40594312)
55. Ell K, Xie B, Quon B, et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol. 2008;26:4488-4496.
56. Strong V, Waters R, Hibberd C, et al. Management of depression for people with cancer (SMaRT Oncology 1): a randomised trial. Lancet. 2008;372:40-48. (Pubitemid 351899234)
57. Moore S. Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs. 2007;30:112-122. (Pubitemid 46573048)
58. Wells KJ, Battaglia TA, Dudley DJ, et al. Patient navigation: state of the art or is it science? Cancer. 2008;113:1999-2010.
59. Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program. Cancer. 2008;113:3391-3399.